National Horizons Centre at Teesside University has launched their new service VecTUs, a pioneering research-grade BioVector production service designed to advance early-stage gene therapy development 🔬
✅ Affordable access, cost and timing efficiencies
✅ Tailored solutions and streamlined process
✅ State-of-the-art facilities
✅ Fostering cutting-edge research
“Using high-spec technical equipment, we are removing the need for re-optimisation of gene therapy vectors upon scale-up, whilst enabling affordable and clinically relevant proof-of-concept studies.”
Linda Popplewell, Professor of Genetic Medicine at Teesside University.
Learn more about VecTUs and get in touch:Â https://teessi.de/vectus
